Skip to main content
Log in

Myoadenylate deaminase deficiency with severe rhabdomyolysis

  • Metabolic Diseases
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

A 13-year-old Turkish girl was admitted because of recurrent episodes of muscle pain and weakness since the age of 5 years. As an outpatient she developed severe acute rhabdomyolysis (myoglobinuria and increased serum creatine kinase level of 19000 units/l). The acute rhabdomyolysis and the preceding episodes of muscle pain and weakness had been induced by exercise. There was no increase in plasma ammonia level during ischaemic forearm exercise test and bicycle ergometry. Myoadenylate deaminase deficiency was proven both histochemically and biochemically. The girl was found to be homozygous for the C 34-T mutation of the AMPD1 gene causing primary myoadenylate deaminase deficiency in skeletal muscle. Both parents and her brother were heterozygous for that mutation. Myoadenylate deaminase deficiency has to be considered as a cause of severe rhabdomyolysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CK:

creatine kinase

CPT:

carnitine palmitoyl transferase

MAD:

myoadenylate deaminase

MADD:

myoadenylate deaminase deficiency

References

  1. Ashwal S, Peckham N (1985) Myoadenylate deaminase deficiency in children. Pediatr Neurol 1:185–191

    PubMed  Google Scholar 

  2. Deufel T, Wieland O (1983) Sensitive assay of carnitine palmitoyl transferase activity in tissue homogenates with a modified spectrometric method for enzymatic carnitine determination. Clin Chim Acta 135:247–251

    PubMed  Google Scholar 

  3. DiMauro S, Papadimitriou A (1986) Carnitine palmitoyltransferase deficiency In: Engel AG, Banker BQ (eds) Myology. McGraw-Hill, New York, pp 1697–1708

    Google Scholar 

  4. DiMauro S, Miranda AF, Hays AP, Franck WA, Hoffman GS, Schoenfeldt RS, Singh N (1980) Myoadenylate deaminase deficiency. Muscle biopsy and muscle culture in a patient with gout. J Neurol Sci 47:191–202

    PubMed  Google Scholar 

  5. Fishbein WN (1986) Myoadenylate deaminase deficiency. In: Engel AG, Banker BQ (eds) Myology. McGraw-Hill, New York, pp 1745–1762

    Google Scholar 

  6. Fishbein WN, Griffin JL, Armbrustmacher VW (1980) Stain for skeletal muscle adenylate deaminase. An effective tetrazolium stain for frozen biopsy specimens. Arch Pathol Lab Med 104:462–466

    PubMed  Google Scholar 

  7. Goebel HH, Bardosi A (1987) Myoadenylate deaminase deficiency. Klin Wochenschr 65:1023–1033

    PubMed  Google Scholar 

  8. Morisaki T, Gross M, Morisaki H (1992) Molecular basis of AMP deaminase deficiency. Proc Natl Acad Sci (in press)

  9. Penn AS (1986) Myoglobinuria. In: Engel AG, Banker BQ (eds) Myology. McGraw-Hill, New York, pp 1785–1805

    Google Scholar 

  10. Reuschenbach C, Zierz S (1988) Mutant carnitine palmitoyl-transferase associated with myoadenylate deaminase deficiency in skeletal muscle. J Pediatr 112:600–603

    PubMed  Google Scholar 

  11. Sabina RL, Swain JL, Holmes EW (1989) Myoadenylate deaminase deficiency. In: Scriver CR, Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1184–1191

    Google Scholar 

  12. Shumate JB, Katnik R, Riuz M, Frieden C, Brooke MH, Caroll JE (1979) Myoadenylate deaminase deficiency. Muscle Nerve 2:213–216

    PubMed  Google Scholar 

  13. Sinkeler SPT, Joosten EMG, Wevers RA, Oei TL, Jacobs AEM, Veerkamp JH, Hamel BCJ (1988) Myoadenylate deaminase deficiency: a clinical, genetic and biochemical study in nine families. Muscle Nerve 2:312–317

    Google Scholar 

  14. Valen PA, Nakayama DA, Veum JA, Wortmann RL (1986) Myoadenylate deaminase deficiency. Diagnosis by forearm ischemic exerise testing. Adv Exp Med Biol 195(B):525–528

    Google Scholar 

  15. Wagner DR, Felbel J, Gresser U, Zöllner N (1991) Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency. Klin Wochenschr 69:251–255

    PubMed  Google Scholar 

  16. Zimmer C, Altenkirch H, Dorfmüller-Küchlin S, Pongratz D, Paetzke I, Gosztonyi G (1991) Type 2a fibre rhabdomyolysis in myoadenylate deaminase deficiency. J Neurol 238:31–33

    PubMed  Google Scholar 

  17. Zöllner N, Reiter S, Gross M, Pongratz D, Reimers CD, Gerbitz K, Paetzke I, Deufel T, Hübner G (1986) Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin Wochenschr 64:1281–1290

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baumeister, F.A.M., Gross, M., Wagner, D.R. et al. Myoadenylate deaminase deficiency with severe rhabdomyolysis. Eur J Pediatr 152, 513–515 (1993). https://doi.org/10.1007/BF01955062

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01955062

Key words

Navigation